Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4INDUSTRY 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Sarcoma 9Ovarian Neoplasms 6Neoplasms 6Liposarcoma 4Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Neoplasms by Site 2Uterine Neoplasms 1Skin Diseases 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Diseases 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Liver Diseases 1Liposarcoma, Myxoid 1Hepatic Insufficiency 1Genital Diseases, Female 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Endocrine Gland Neoplasms 1Carcinoma 1Breast Diseases 1Adnexal Diseases 1

Interventions

Trabectedin 4Doxorubicin 4toripalimab 2brigimadlin 2belinostat 2Fulvestrant 2Dexamethasone 2tanespimycin 1soblidotin 1siremadlin 1selinexor 1ridaforolimus 1ribociclib 1pembrolizumab 1olaratumab 1milademetan 1enzalutamide 1cemiplimab 1atezolizumab 1TTI-621 1Sugars 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Midazolam 1Letrozole 1Injections 1Immunotherapy 1Imatinib Mesylate 1Ifosfamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Liposarcoma × Trabectedin × Clear all
NCT04979442 2025-01-14

MANTRA

Rain Oncology Inc

Phase 3 Terminated
175 enrolled 16 charts
Sarcoma

Liposarcoma, Sarcoma

NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Completed
16 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT00060944 2014-09-08

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
271 enrolled 13 charts
Sarcoma

Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Neoplasms

NCT00579501 2014-05-07

Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
29 enrolled 7 charts
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡